Latest JRS Pharma News

  • February 22, 2017  JRS PHARMA Expands their Product Portfolio with the Addition of the Povidone Family

    JRS PHARMA Expands their Product Portfolio with the Addition of the Povidone Family

    JRS PHARMA has announced the worldwide release of the Povidone Family product line, the latest addition to their excipients portfolio. This product line consists of three products: VIVAPHARM® PVP (Povidone), VIVAPHARM® PVP/VA 64 (Copovidone), and VIVAPHARM® PVPP (Crospovidone).

  • August 18, 2016  JRS PHARMA Now Direct in India

    JRS PHARMA products can now be purchased direct in India. All business has been transferred from S. Zhaveri Pharmakem Pvt. Ltd. to Rettenmaier India Pvt. Ltd., a wholly owned subsidiary of the JRS Group ( J. RETTENMAIER & Söhne)

  • July 20, 2016  JRS PHARMA to Offer Povidone Products

    JRS PHARMA, headquartered in Germany, has entered into a joint venture agreement with SSP, headquartered in Chongqing, China, for the commercialization of povidone products. The new JV company is Star-Tech & JRS Specialty Products.

  • March 21, 2016  New Dextrates Facility Construction Nearing Completion in Cedar Rapids, IA

    JRS Pharma continues to expand and advance our manufacturing capabilities. We are pleased to share that the construction of our new manufacturing facility for dextrates products will soon be complete.

  • February 29, 2016  Michael Hampel Named New CEO of JRS PHARMA LP

    We are excited to announce that Michael Hampel has been named the new CEO of our North American Pharma division.

 
Request Sample     Careers     Contact Us     Site Map     T&C
Stay Connected.     LinkedIn  Youtube 
 

Copyright 2017, JRS PHARMA - All Rights Reserved